AITechFundingNewsabout 2 hours ago
Swiss pharma backed Octozi before US VCs
5 min read
Octozi raised $3 million in seed funding led by Surface Ventures, with Remarkable Ventures joining. Swiss pharmaceutical company Debiopharm's venture arm invested at pre-seed before any US investors. The AI platform for clinical trial data cleaning reduced a 10-month process to one month in Phase III studies.
Level
Hype check
Tap to vote and see what everyone thinks.
